Hospital Universitario Cruces

Barakaldo 48903

5 studies enrolling now · 17 studies all time

What they study most

ALK-positive Histiocytosis, Clostridioides Difficile Infection, Erdheim-Chester Disease (ECD), Focal Epilepsy, Focal Onset Seizures, Huntington Disease, Indeterminate Dendritic Cell Histiocytosis, Low-grade Glioma, Malignant Histiocytic Neoplasm (MHN), Methylmalonic Acidemia, Mixed Histiocytosis (MXH), Multicentric Reticulohistiocytoma (MRH)

Studies at this site

• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• A Retrospective Study to Characterize Participants With Propionic Acidemia — Recruiting now
• International Rare Histiocytic Disorders Registry (IRHDR) — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD) — Completed
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD — Running, not enrolling
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia — Stopped early
• Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study — Available (expanded access)
• A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease — Completed
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — Running, not enrolling
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection — Completed
• Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis — Completed
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes — Completed